Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Long-Term Growth Rate is Expected for the C-Reactive Protein Testing Market Between 2025 and 2034?

Over the past few years, the c-reactive protein testing market has seen a consistent increase in its size. It is predicted to expand from $3.45 billion in 2024 to $3.55 billion in 2025, experiencing a compound annual growth rate (CAGR) of 2.9%. This progression during the historic period is largely due to a rise in the occurrence of inflammatory diseases, assessments of cardiovascular risk, a growing elderly population, enhanced healthcare infrastructure, and the implementation of healthcare screening programs.

The market size of c-reactive protein testing is projected to witness substantial expansion in the upcoming years, expected to reach $4.35 billion by 2029, with a compound annual growth rate (CAGR) of 5.2%. This anticipated growth in the forecast period is linked with factors such as increasing rates of obesity, personalized medicine and biomarkers, the adoption of telehealth and remote monitoring, the emphasis on early detection of diseases, and lifestyle-related inflammation. Key trends expected during the forecast period encompass advancements in diagnostic testing, the advent of wearable health technology, technological solutions, strategic alliances, and the introduction of industry 4.0.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the c-reactive protein testing Market?

The surge in cardiovascular disease (CVD) cases is anticipated to boost the c-reactive protein testing market. CVD encompasses heart-related conditions such as blood clots, diseased vessels, and structural problems. The precise origin of CVD is not clear, but many elements can escalate the likelihood of its occurrence. Behaviors like unbalanced diet, insufficient exercise, smoking, and alcohol consumption form one such risk factor, leading to a buildup of fatty plaques within the arteries (atherosclerosis), subsequently enhancing the chances of blood clots. Such behavioral risks lead to heightened blood pressure, sugar levels, blood lipids, weight gain and obesity. The growing prevalence of cardiovascular diseases necessitates c-reactive protein testing for diagnosis or to foresee the probability of cardiovascular concerns, at par or better than cholesterol level prediction. As an instance, the Institute for Health Metrics and Evaluation cited in December 2023 that global mortalities from CVDs had hit 19.8 million in 2022, with ischemic heart disease being the primary cause with 108.8 deaths per 100,000 individuals. Higher systolic blood pressure was the largest contributor to disability-adjusted life years (DALYs) linked to CVD, while dietary risks and air pollution were the key behavioral and environmental contributors of this global affliction.

Request Your Free C-Reactive Protein Testing Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

What Are the Key Firms That Are Driving Transformation in the C-Reactive Protein Testing Market?

Major companies operating in the c-reactive protein testing market include:

• Thermo Fisher Scientific Inc._x000D_

• F Hoffmann-La Roche AG_x000D_

• Danaher Corporation_x000D_

• Quest Diagnostics Incorporated_x000D_

• Siemens AG_x000D_

What Current Trends in the C-Reactive Protein Testing Market Should Industry Players Pay Attention To?

The c-reactive protein testing market is experiencing a key trend of technological innovation within its measuring devices. Major players in this market are concentrating on delivering technologically innovative solutions in order to solidify their market standing. They are incorporating next-generation c-reactive testing technologies into their methods and developing advanced solutions that offer high output and multiple use capabilities. For instance, Aidian, a diagnostics testing firm based in Finland, launched the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. The kit allows for the consistent production of two results, covering a broad spectrum of CRP and Hb, from just one sample and one analysis. This broad-scale CRP test enables evaluations of conditions such as neonatal sepsis, assessment of disease severity in cases of COPD (chronic obstructive pulmonary disease), and assistance in cardiovascular risk analysis.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Key Segments Define the Structure of the C-Reactive Protein Testing Market and Their Growth Potential?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

What Regions Are Driving Expansion in the C-Reactive Protein Testing Market?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the C-Reactive Protein Testing Market Categorized and Defined in the Industry?

C-reactive protein testing measures the level of c-reactive protein (CRP) in the blood. CRP is a liver-produced protein released into the bloodstream due to inflammation. When the body is wounded or infected, inflammation is the body’s way of protecting the tissues. CRP testing is generally used to diagnose inflammation caused due to an infection.

Browse Through More Similar Reports By The Business Research Company:

Protein Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Oral Biologics & Biosimilar Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Protein Labeling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: